In the shadow of a pandemic that confounded prediction, researchers at Massachusetts General Hospital found an unlikely ally in an old and familiar tool: a routine blood test, long used to detect anaemia and heart disease, that quietly revealed which COVID-19 patients were most likely to die. The red cell distribution width, or RDW, proved nearly three times more predictive of mortality than chance alone — and held its power even when age and underlying conditions were accounted for. Science, in this moment, did not arrive with something new, but with a deeper reading of something already in h
BreakingNews.ie
· Sep 23, 2020
· health
· 2 min de leitura
High
Apuração: Verificado
Blood test could predict Covid-19 mortality risk, study finds
Elevated RDW values correlate with increased mortality risk in COVID-19 patients, indicating potential for identifying those at higher risk of death.
◉
Health & Medicine
8046 artigos relacionados
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% correspondência
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% correspondência
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% correspondência
Canada faces new COVID epidemic, not third wave, as variants target di…
The Globe and Mail · 99% correspondência
Researchers identify new Ebola variant, propose repurposed drug treatm…
Medical Xpress · 99% correspondência
Cobertura Relacionada
Google News · Aug 19
Welsh Teen's Ovarian Cancer Diagnosis Triggers Sudden Menopause
A teenager from Caernarfon experienced sudden onset menopause following an ovarian cancer diagnosis, highlighting unexpe…
JNS.org · Aug 19 Israeli study: Focused attention may reduce inflammatory responseBar-Ilan University researchers found that deliberately focusing attention on inflamed skin areas reduced inflammatory r…
foodsafetynews.com · Aug 19 UK Salmonella outbreak sickens 207, linked to imported eggsA Salmonella outbreak across the UK has infected 207 people with one death, traced to contaminated imported eggs served …
eNCA · Aug 19 DRC Ebola outbreak spreading faster than any previous epidemic, WHO warnsWHO warns the DRC Ebola outbreak is moving faster than any previous epidemic, with over 2,300 deaths from nearly 5,000 c…
Impacto Geopolítico
🌎
Medical research on COVID-19 mortality prediction has minimal geopolitical implications; primarily a public health advancement with potential global healthcare benefits.
Escalation Risk
low
Confidence
HIGH
No significant power shifts. This is a scientific discovery that could benefit all nations equally if adopted universally in healthcare systems.
Viés e Enquadramento
⚖
Article presents medical research findings on RDW blood test correlation with COVID-19 mortality in straightforward, factual manner with minimal apparent bias.
Bias Direction
center
Confidence
MED
Science-based reporting using expert authority and empirical data. Frames discovery as potentially beneficial for patient care through early risk identification and targeted interventions.
surprised to find
highly correlated
complicated changes
aggressive interventions
Limitations or criticisms of the study methodology
Perspectives from independent researchers not involved in the study
Practical implementation challenges or barriers
Cost-effectiveness analysis or healthcare access considerations
Patient perspectives or experiences
Competing or contradictory research findings
Lente Econômica
📈
Blood test discovery (RDW) could enable early identification of high-risk COVID-19 patients, potentially reducing mortality through targeted interventions and improving healthcare resource allocation.
Market Signal
bullish
Confidence
MED
Healthcare/Diagnostics
Pharmaceutical/Biotech
Medical Devices
Hospital Services
Insurance/Healthcare Administration
Patients benefit from earlier risk stratification enabling timely aggressive treatment, potentially reducing mortality rates and improving outcomes. May reduce unnecessary hospitalizations for low-risk patients and lower out-of-pocket costs through more efficient care pathways.
Regulatory bodies (FDA, EMA) may expedite approval of RDW-based diagnostic protocols. Healthcare systems could adopt RDW screening as standard COVID-19 admission procedure. Insurance reimbursement policies may evolve to incentivize early risk assessment. Public health agencies may integrate this into pandemic preparedness frameworks.